This AOP is licensed under the BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.

AOP: 606

Title

A descriptive phrase which references both the Molecular Initiating Event and Adverse Outcome.It should take the form “MIE leading to AO”. For example, “Aromatase inhibition leading to reproductive dysfunction” where Aromatase inhibition is the MIE and reproductive dysfunction the AO. In cases where the MIE is unknown or undefined, the earliest known KE in the chain (i.e., furthest upstream) should be used in lieu of the MIE and it should be made clear that the stated event is a KE and not the MIE.  More help

Ecdysone receptor antagonism leading to mortality via inhibition of chitin synthase 1

Short name
A name that succinctly summarises the information from the title. This name should not exceed 90 characters. More help
EcR antagonism leading to mortality via inhibition of Chs1
The current version of the Developer's Handbook will be automatically populated into the Handbook Version field when a new AOP page is created.Authors have the option to switch to a newer (but not older) Handbook version any time thereafter. More help
Handbook Version v2.7

Graphical Representation

A graphical representation of the AOP.This graphic should list all KEs in sequence, including the MIE (if known) and AO, and the pair-wise relationships (links or KERs) between those KEs. More help
Click to download graphical representation template Explore AOP in a Third Party Tool

Authors

The names and affiliations of the individual(s)/organisation(s) that created/developed the AOP. More help

You Song & co-authors

Norwegian Institute for Water Research (NIVA), Økernveien 94, N-0579, Oslo, Norway

Point of Contact

The user responsible for managing the AOP entry in the AOP-KB and controlling write access to the page by defining the contributors as described in the next section.   More help

Contributors

Users with write access to the AOP page.  Entries in this field are controlled by the Point of Contact. More help
  • You Song

Coaches

This field is used to identify coaches who supported the development of the AOP.Each coach selected must be a registered author. More help

OECD Information Table

Provides users with information concerning how actively the AOP page is being developed and whether it is part of the OECD Workplan and has been reviewed and/or endorsed. OECD Project: Assigned upon acceptance onto OECD workplan. This project ID is managed and updated (if needed) by the OECD. OECD Status: For AOPs included on the OECD workplan, ‘OECD status’ tracks the level of review/endorsement of the AOP . This designation is managed and updated by the OECD. Journal-format Article: The OECD is developing co-operation with Scientific Journals for the review and publication of AOPs, via the signature of a Memorandum of Understanding. When the scientific review of an AOP is conducted by these Journals, the journal review panel will review the content of the Wiki. In addition, the Journal may ask the AOP authors to develop a separate manuscript (i.e. Journal Format Article) using a format determined by the Journal for Journal publication. In that case, the journal review panel will be required to review both the Wiki content and the Journal Format Article. The Journal will publish the AOP reviewed through the Journal Format Article. OECD iLibrary published version: OECD iLibrary is the online library of the OECD. The version of the AOP that is published there has been endorsed by the OECD. The purpose of publication on iLibrary is to provide a stable version over time, i.e. the version which has been reviewed and revised based on the outcome of the review. AOPs are viewed as living documents and may continue to evolve on the AOP-Wiki after their OECD endorsement and publication.   More help
OECD Project # OECD Status Reviewer's Reports Journal-format Article OECD iLibrary Published Version
This AOP was last modified on October 01, 2025 15:54

Revision dates for related pages

Page Revision Date/Time
Increase, Ecdysone receptor antagonism September 29, 2025 05:17
Decrease, Mis-timed ecdysone receptor-responsive nuclear receptor cascade September 29, 2025 05:18
Inhibition, Chitin synthase 1 February 24, 2021 04:41
Decrease, Cuticular chitin content February 17, 2021 05:37
Increase, Premature molting February 17, 2021 05:30
Increase, Mortality October 26, 2020 05:18
Increase, EcR antagonism leads to Decrease, Mis-timed EcR-responsive NR cascade September 29, 2025 05:19
Decrease, Mis-timed EcR-responsive NR cascade leads to Inhibition, CHS-1 September 29, 2025 08:20
Inhibition, CHS-1 leads to Decrease, Cuticular chitin content February 17, 2021 07:50
Decrease, Cuticular chitin content leads to Increase, Premature molting February 17, 2021 08:20
Increase, Premature molting leads to Increase, Mortality February 17, 2021 08:47
Cucurbitacin B October 01, 2025 07:13
Cucurbitacin D October 01, 2025 07:13
Ketoconazole May 02, 2017 11:08

Abstract

A concise and informative summation of the AOP under development that can stand-alone from the AOP page. The aim is to capture the highlights of the AOP and its potential scientific and regulatory relevance. More help

This Adverse Outcome Pathway (AOP) describes how antagonism of the ecdysone receptor (EcR) disrupts endocrine signaling in arthropods, leading to premature molting and mortality. EcR is a nuclear receptor that mediates transcriptional responses to ecdysteroids, which regulate cuticle synthesis, chitin deposition, and developmental transitions. Inhibition of EcR prevents normal progression of the ecdysteroid-responsive nuclear receptor cascade, leading to reduced expression of chitin synthase 1 and reduced cuticular chitin content. These molecular and cellular disruptions compromise the structural integrity of the exoskeleton and trigger premature or defective molting. Ultimately, this leads to organism-level mortality. This AOP provides a mechanistic framework for assessing the hazard potential of EcR antagonists, supporting regulatory efforts to evaluate risks to non-target arthropods.

AOP Development Strategy

Context

Used to provide background information for AOP reviewers and users that is considered helpful in understanding the biology underlying the AOP and the motivation for its development.The background should NOT provide an overview of the AOP, its KEs or KERs, which are captured in more detail below. More help

EcR antagonists include experimental endocrine disruptors and potential environmental contaminants that interfere with steroid signaling in arthropods. Although most registered insecticides act as EcR agonists, antagonists represent a plausible mode of endocrine disruption with ecological significance. Understanding how inhibition of EcR leads to organismal failure provides a basis for chemical safety assessment.

Strategy

Provides a description of the approaches to the identification, screening and quality assessment of the data relevant to identification of the key events and key event relationships included in the AOP or AOP network.This information is important as a basis to support the objective/envisaged application of the AOP by the regulatory community and to facilitate the reuse of its components.  Suggested content includes a rationale for and description of the scope and focus of the data search and identification strategy/ies including the nature of preliminary scoping and/or expert input, the overall literature screening strategy and more focused literature surveys to identify additional information (including e.g., key search terms, databases and time period searched, any tools used). More help

The AOP was developed using targeted literature reviews of EcR function, chitin biosynthesis, and molting regulation in insects and crustaceans. Searches in PubMed, Web of Science, and Scopus were conducted using terms such as ecdysone receptor antagonist, chitin synthase, cuticle formation, premature molting, and ecdysteroid signaling disruption. Empirical studies in Drosophila melanogaster, Manduca sexta, lepidopteran pests, and crustaceans informed the selection of key events (KEs) and their relationships. Expert input and prior reviews of molting endocrinology were used to frame the AOP in a regulatory context.

Summary of the AOP

This section is for information that describes the overall AOP.The information described in section 1 is entered on the upper portion of an AOP page within the AOP-Wiki. This is where some background information may be provided, the structure of the AOP is described, and the KEs and KERs are listed. More help

Events:

Molecular Initiating Events (MIE)
An MIE is a specialised KE that represents the beginning (point of interaction between a prototypical stressor and the biological system) of an AOP. More help
Key Events (KE)
A measurable event within a specific biological level of organisation. More help
Adverse Outcomes (AO)
An AO is a specialized KE that represents the end (an adverse outcome of regulatory significance) of an AOP. More help
Type Event ID Title Short name
MIE 2374 Increase, Ecdysone receptor antagonism Increase, EcR antagonism
KE 2375 Decrease, Mis-timed ecdysone receptor-responsive nuclear receptor cascade Decrease, Mis-timed EcR-responsive NR cascade
KE 1522 Inhibition, Chitin synthase 1 Inhibition, CHS-1
KE 1523 Decrease, Cuticular chitin content Decrease, Cuticular chitin content
AO 1524 Increase, Premature molting Increase, Premature molting
AO 350 Increase, Mortality Increase, Mortality

Relationships Between Two Key Events (Including MIEs and AOs)

This table summarizes all of the KERs of the AOP and is populated in the AOP-Wiki as KERs are added to the AOP.Each table entry acts as a link to the individual KER description page. More help

Network View

This network graphic is automatically generated based on the information provided in the MIE(s), KEs, AO(s), KERs and Weight of Evidence (WoE) summary tables. The width of the edges representing the KERs is determined by its WoE confidence level, with thicker lines representing higher degrees of confidence. This network view also shows which KEs are shared with other AOPs. More help

Prototypical Stressors

A structured data field that can be used to identify one or more “prototypical” stressors that act through this AOP. Prototypical stressors are stressors for which responses at multiple key events have been well documented. More help

Life Stage Applicability

The life stage for which the AOP is known to be applicable. More help
Life stage Evidence
Juvenile High
Adult High

Taxonomic Applicability

Latin or common names of a species or broader taxonomic grouping (e.g., class, order, family) can be selected.In many cases, individual species identified in these structured fields will be those for which the strongest evidence used in constructing the AOP was available. More help
Term Scientific Term Evidence Link
Arthropoda Arthropoda High NCBI

Sex Applicability

The sex for which the AOP is known to be applicable. More help
Sex Evidence
Unspecific Moderate

Overall Assessment of the AOP

Addressess the relevant biological domain of applicability (i.e., in terms of taxa, sex, life stage, etc.) and Weight of Evidence (WoE) for the overall AOP as a basis to consider appropriate regulatory application (e.g., priority setting, testing strategies or risk assessment). More help

The overall weight of evidence supporting this AOP is strong, with high biological plausibility and consistent empirical data linking EcR antagonism to premature molting and mortality. EcR is a well-characterized nuclear receptor that orchestrates the ecdysteroid-responsive transcriptional cascade necessary for normal cuticle formation and molting. Antagonism of this receptor is expected to impair downstream gene expression, including chitin synthase 1, leading to reduced chitin deposition in the cuticle. These disruptions compromise the integrity of the exoskeleton and destabilize the timing of developmental transitions, resulting in premature molting events that are incompatible with survival.

Essentiality of the key events is well supported: genetic knockouts, RNAi knockdowns, and pharmacological inhibition of EcR or chitin synthase all produce the predicted downstream outcomes, culminating in lethality. Empirical support across taxa (insects, crustaceans) demonstrates that the mechanistic linkages are conserved within arthropods. Although quantitative understanding of dose–response relationships and thresholds for molting disruption remains limited, the coherence of the biological mechanism, reproducibility of the outcome, and conservation of the underlying pathways provide high confidence in the reliability of this AOP.

Given its strong biological plausibility and empirical support, this AOP has clear regulatory relevance for evaluating the risks of chemicals with EcR antagonistic properties. While further quantitative studies would enhance predictive applications, the current evidence base is sufficient to support use in chemical screening, prioritization, and ecological risk assessment of non-target arthropods.

Domain of Applicability

Addressess the relevant biological domain(s) of applicability in terms of sex, life-stage, taxa, and other aspects of biological context. More help

The domain of applicability of this AOP is defined primarily by the biology of the ecdysone receptor (EcR) and the molting process. Because EcR signaling and chitin biosynthesis are highly conserved within arthropods, this AOP is broadly relevant across multiple taxa, developmental stages, and environmental contexts.

  • Taxonomic applicability:

    • Insects: Strong evidence is available for holometabolous insects (Drosophila melanogaster, Manduca sexta, Bombyx mori, Lepidopteran crop pests), where EcR function and its transcriptional cascade have been extensively studied. Hemimetabolous insects (e.g., locusts, cockroaches) also rely on EcR signaling, though fewer data are available for EcR antagonism specifically.

    • Crustaceans: Increasing evidence supports applicability in aquatic species (e.g., Daphnia magna, Carcinus maenas, Penaeus spp.), which undergo chitin-based molting under EcR regulation. Transcriptomic and physiological studies demonstrate conservation of EcR function and chitin synthase regulation.

    • Other arthropods: Applicability is expected in arachnids and myriapods, given the conserved role of EcR and chitin in exoskeleton formation, but direct empirical data remain scarce.

  • Sex applicability: The pathway is relevant to both sexes. EcR signaling and molting are not sex-specific processes; therefore, both male and female individuals are equally susceptible to antagonism.

  • Life-stage applicability: This AOP is most relevant to juvenile and larval stages undergoing active molting. Premature molting in these stages leads directly to impaired growth, developmental arrest, or death. In adults, EcR signaling plays reduced roles, although cuticular renewal processes may still be impacted in some taxa (e.g., crustacean molting cycles).

  • Environmental context: The AOP applies in both terrestrial and aquatic ecosystems, wherever arthropods are exposed to environmental contaminants with EcR antagonistic activity. Aquatic crustaceans are particularly vulnerable given their continuous molting cycles and exposure pathways.

In summary, the domain of applicability encompasses a broad range of arthropod taxa, both sexes, and primarily larval or juvenile stages. While most supporting evidence comes from model insects and select crustaceans, the high conservation of the underlying pathways supports a wide biological relevance of this AOP.

Essentiality of the Key Events

The essentiality of KEs can only be assessed relative to the impact of manipulation of a given KE (e.g., experimentally blocking or exacerbating the event) on the downstream sequence of KEs defined for the AOP. Consequently, evidence supporting essentiality is assembled on the AOP page, rather than on the independent KE pages that are meant to stand-alone as modular units without reference to other KEs in the sequence. The nature of experimental evidence that is relevant to assessing essentiality relates to the impact on downstream KEs and the AO if upstream KEs are prevented or modified. This includes: Direct evidence: directly measured experimental support that blocking or preventing a KE prevents or impacts downstream KEs in the pathway in the expected fashion. Indirect evidence: evidence that modulation or attenuation in the magnitude of impact on a specific KE (increased effect or decreased effect) is associated with corresponding changes (increases or decreases) in the magnitude or frequency of one or more downstream KEs. More help

The essentiality of the key events (KEs) in this AOP is strongly supported by experimental manipulations, including genetic knockouts, RNA interference (RNAi), pharmacological inhibition, and rescue assays. Because molting is a tightly regulated process, disruption at any level of the EcR signaling–chitin synthesis axis produces predictable downstream consequences, culminating in lethality.

  • MIE: EcR antagonism

    • Evidence: EcR is the central nuclear receptor mediating ecdysteroid signaling. Competitive antagonists or dominant-negative EcR mutations prevent activation of downstream nuclear receptor genes (e.g., HR3, Ftz-f1).

    • Essentiality: High. Blocking EcR function prevents initiation of the molting transcriptional cascade. Restoration of EcR function rescues normal molting.

  • KE: Decreased EcR-responsive transcriptional cascade

    • Evidence: Knockdown of EcR or RXR/USP (the EcR heterodimer partner) leads to broad suppression of ecdysteroid-responsive genes, including those necessary for cuticle synthesis.

    • Essentiality: High. These nuclear receptors act as competence factors for molting; without their activation, progression to chitin synthase induction and cuticle deposition is blocked.

  • KE: Decreased chitin synthase 1 expression

    • Evidence: RNAi knockdown of chitin synthase genes in Drosophila and Tribolium results in defective cuticle formation, molting arrest, and lethality. In crustaceans, inhibition of chitin synthase similarly disrupts exoskeletal renewal.

    • Essentiality: High. Chitin synthase is the rate-limiting enzyme for polymerization of chitin; its disruption directly impairs cuticle formation.

  • KE: Decreased cuticular chitin content

    • Evidence: Pharmacological inhibitors of chitin synthesis (e.g., benzoylureas) and genetic knockdowns lead to reduced chitin levels and fragile cuticles. These effects consistently precede defective molting and mortality.

    • Essentiality: High. Adequate chitin deposition is indispensable for structural integrity of the exoskeleton.

  • KE: Increased premature molting

    • Evidence: Experimental reduction of chitin synthesis or EcR signaling often triggers mistimed molts, which are non-viable. Rescue of chitin deposition (e.g., by overexpression of chitin synthase) prevents premature molting in experimental systems.

    • Essentiality: High. Premature or defective molting is directly incompatible with survival in arthropods.

  • AO: Mortality

    • Evidence: Mortality is the inevitable outcome of premature or incomplete molting, as arthropods cannot survive without shedding the old cuticle and forming a new one. This has been repeatedly observed in laboratory and field studies with EcR-targeting compounds.

Overall assessment: The essentiality of the key events in this AOP is considered high. Direct experimental manipulations at multiple points in the pathway (EcR function, nuclear receptor cascade, chitin synthase expression, chitin deposition) consistently demonstrate that disruption prevents progression to the next KE and results in mortality. Rescue studies further confirm causality. Together, these data provide strong confidence that the KEs in this AOP are indispensable for normal molting and survival.

Evidence Assessment

Addressess the biological plausibility, empirical support, and quantitative understanding from each KER in an AOP. More help

KER 2374 → 2373 (EcR antagonism → Decreased EcR-responsive cascade)

  • Biological plausibility: Strong; EcR is a master regulator of steroid-induced transcription.

  • Empirical support: Inhibitors of EcR block induction of nuclear receptor genes (e.g., HR3, Ftz-f1).

KER 2373 → 1522 (Decreased nuclear receptor cascade → Decreased chitin synthase 1 expression)

  • Biological plausibility: Strong; transcription of chitin synthase genes is steroid-dependent.

  • Empirical support: RNAi knockdown of nuclear receptor genes reduces chitin synthase expression in insects.

KER 1522 → 1523 (Decreased chitin synthase 1 → Decreased cuticular chitin content)

  • Biological plausibility: Strong; chitin synthase is the rate-limiting enzyme for chitin polymerization.

  • Empirical support: Chitin synthase knockdown or inhibition reduces chitin deposition in cuticle.

KER 1523 → 1524 (Decreased cuticular chitin → Increased premature molting)

  • Biological plausibility: Strong; reduced chitin weakens cuticle structure and destabilizes molt timing.

  • Empirical support: Experimental reduction in cuticular chitin triggers defective and premature molts.

KER 1524 → 350 (Premature molting → Mortality)

  • Biological plausibility: Strong; premature molting results in incomplete development, loss of protection, and organismal death.

  • Empirical support: Consistently observed in insects exposed to EcR inhibitors or with disrupted chitin biosynthesis.

Known Modulating Factors

Modulating factors (MFs) may alter the shape of the response-response function that describes the quantitative relationship between two KES, thus having an impact on the progression of the pathway or the severity of the AO.The evidence supporting the influence of various modulating factors is assembled within the individual KERs. More help
  • Developmental stage: Premature molting occurs only if antagonism coincides with periods of ecdysteroid signaling during cuticle deposition.

  • Species differences: Variation in EcR isoforms and chitin metabolic pathways can modulate sensitivity. Lepidopterans and dipterans often show higher sensitivity.

  • Nutritional state: Energy and substrate availability for chitin biosynthesis (e.g., glucose, UDP-N-acetylglucosamine pools) modulate outcomes.

  • Environmental factors: Temperature and humidity affect cuticle synthesis and molting success.

  • Chemical properties: Antagonist potency, receptor affinity, and bioavailability influence the severity and timing of KE progression.

Modulating Factor (MF) Influence or Outcome KER(s) involved
     

Quantitative Understanding

Optional field to provide quantitative weight of evidence descriptors.  More help
  • MIE (EcR antagonism): Binding affinities and antagonist activities for EcR have been documented for some chemicals (e.g., dibenzoylhydrazines in antagonist mode, experimental scaffolds), but quantitative receptor occupancy thresholds remain underdeveloped.

  • Nuclear receptor cascade → Chitin synthase: Genetic knockdown studies show strong temporal concordance; suppression of EcR target gene cascades reduces CHS1 expression. Quantitative dose–response data are limited.

  • Chitin synthase → Cuticular chitin: Experimental knockdown of CHS1 yields proportionally reduced chitin levels; threshold-like relationships exist where cuticle integrity is lost below critical chitin levels.

  • Cuticular chitin → Premature molting: Reduced chitin triggers incomplete or premature molting, a deterministic relationship supported by multiple insect models.

  • Premature molting → Mortality: Strong evidence that unsuccessful molts correlate with high mortality, often >80–90% in experimental studies.

Overall confidence: Moderate to high for qualitative predictions, moderate for quantitative extrapolation. More targeted data are needed to establish predictive quantitative KERs.

Considerations for Potential Applications of the AOP (optional)

Addressess potential applications of an AOP to support regulatory decision-making.This may include, for example, possible utility for test guideline development or refinement, development of integrated testing and assessment approaches, development of (Q)SARs / or chemical profilers to facilitate the grouping of chemicals for subsequent read-across, screening level hazard assessments or even risk assessment. More help

This AOP provides a mechanistic framework that can be applied in several regulatory and scientific contexts related to the hazard and risk assessment of chemicals with EcR antagonistic activity. Because EcR is a central regulator of arthropod molting, disruption of its signaling cascade has direct consequences on survival and population dynamics. Thus, this AOP can be applied across multiple levels of chemical assessment, ranging from early screening to ecological risk evaluation.

1. Screening and Prioritization of Chemicals The AOP identifies EcR antagonism as a molecular initiating event that can be probed with receptor-binding assays, reporter gene systems, or in silico docking models. These methods can be used in high-throughput screening programs to prioritize chemicals for further testing. Chemicals showing EcR antagonist activity could be flagged for potential concern regarding non-target arthropods.

2. Support for Test Guideline Development and Refinement This AOP highlights specific endpoints such as EcR-responsive gene expression, chitin synthase 1 expression, and cuticular chitin deposition, which could be integrated into OECD test guidelines or used as biomarkers in modified protocols. These endpoints offer mechanistic markers that can provide early evidence of adverse outcomes before organismal lethality occurs.

3. Integrated Approaches to Testing and Assessment (IATA) The pathway offers opportunities to combine in vitro assays, transcriptomic biomarkers, and cuticle composition measurements with in vivo molting assays to create tiered assessment strategies. Such approaches can reduce reliance on animal testing, while still ensuring regulatory robustness by linking molecular and cellular endpoints to organismal outcomes.

4. Grouping and Read-Across The mechanistic understanding of EcR antagonism can support grouping of chemicals with similar structural or functional properties. This enables the use of read-across approaches in regulatory submissions, where data from one compound can be applied to structurally related analogues. In addition, development of (Q)SAR models based on chemical structural features associated with EcR antagonism can be informed by this AOP.

5. Ecological Risk Assessment Because molting is essential for arthropod growth and reproduction, disruption of this process has direct implications for population dynamics and ecosystem function. This AOP provides a scientifically supported mechanistic link between receptor-level antagonism and mortality, which can be used in ecological risk assessment frameworks. This is particularly relevant for assessing risks of environmental contaminants to non-target aquatic crustaceans and beneficial insects such as pollinators.

6. Regulatory Decision-Making Regulators can use this AOP as part of weight-of-evidence evaluations for chemicals suspected to interfere with arthropod endocrine systems. The structured mechanistic evidence can be applied to inform decisions on chemical approval, restriction, or mitigation measures aimed at protecting non-target species.

Overall, this AOP strengthens the scientific basis for linking molecular and cellular perturbations to adverse ecological outcomes, and supports the transition toward more predictive and mechanistically informed regulatory toxicology.

References

List of the literature that was cited for this AOP. More help